Neurochemical Research

, Volume 23, Issue 5, pp 667–673

Effect of Theanine, r-Glutamylethylamide, on Brain Monoamines and Striatal Dopamine Release in Conscious Rats

  • Hidehiko Yokogoshi
  • Miki Kobayashi
  • Mikiko Mochizuki
  • Takehiko Terashima

Abstract

Theanine, r-glutamylethylamide, is one of the major components of amino acids in Japanese green tea. Effect of theanine on brain amino acids and monoamines, and the striatal release of dopamine (DA) was investigated. Determination of amino acids in the brain after the intragastric administration of theanine showed that theanine was incorporated into brain through blood-brain barrier via leucine-preferring transport system. The concentrations of norepinephrine, 3,4-dihydroxyphenylacetic acid (DOPAC) and 5-hydroxyindole acetic acid (5HIAA) in the brain regions were unaffected by the theanine administration except in striatum. Theanine administration caused significant increases in serotonin and/or DA concentrations in the brain, especially in striatum, hypothalamus and hippocampus. Direct administration of theanine into brain striatum by microinjection caused a significant increase of DA release in a dose-dependent manner. Microdialysis of brain with calcium-free Ringer buffer attenuated the theanine-induced DA release. Pretreatment with the Ringer buffer containing an antagonist of non-NMDA (N-methyl-D-aspartate) glutamate receptor, MK-801, for 1 hr did not change the significant increase of DA release induced by theanine. However, in the case of pretreatment with AP-5, (±)-2-amino-5-phosphonopentanoic acid; antagonist of NMDA glutamate receptor, the theanine-induced DA release from striatum was significantly inhibited. These results suggest that theanine might affect the metabolism and/or the release of some neurotransmitters in the brain, such as DA.

Theanine serotonin dopamine microdialysis glutamate receptor NMDA receptor 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

REFERENCES

  1. 1.
    Sakato, Y. 1949. Studies on the chemical constituent of tea. Part III. On a new amide theanine. Nippon Nogeikagaku Kaishi 23:262–267.Google Scholar
  2. 2.
    Kuhn, D. M., Wolf, W. A., and Lovenberg, W. 1980. Review of the role of the central serotonergic neuronal system in blood pressure regulation. Hypertension 2:243–255.Google Scholar
  3. 3.
    Bresnahan, M. R., Hatzinikolaw, P., Brunner, H. R., and Gavras, H. 1980. Effect of tyrosine infusion in normotensive and hypertensive rats. Am. J. Physiol. 239:4206.Google Scholar
  4. 4.
    Lown, B., Temte, J. V., and Reich, P. 1976. Basis for recurring ventricular fibrillation in the absence of coronary heart disease and its management. New Eng. J. Med. 294:623–629.Google Scholar
  5. 5.
    Sved, A. F., Fernstrom, J. D., and Wurtman, R. J. 1979. Tyrosine administration reduces blood pressure and enhances brain norepinephrine release in spontaneously hypertensive rats. Proc. Natl. Acad. Sci., U.S.A. 76:3511–3514.Google Scholar
  6. 6.
    Yokogoshi, H., Kato, Y., Sagesaka, Y., Matsuura, T., Kakuda, T., and Takeuchi, N. 1995. Reduction effect of theanine on blood pressure and brain 5-hydroxyindoles in spontaneously hypertensive rats. Biosci. Biotech. Biochem. 59:615–618.Google Scholar
  7. 7.
    Oldendorf, W. H., and Szabo, J. 1976. Amino acid assignment to one of three blood-brain barrier amino acid carriers. Am. J. Physiol. 230:94–98.Google Scholar
  8. 8.
    Christensen, H. N. 1979. Developments in amino acid transport, illustrated for the blood-brain barrier. Biochem. Pharmacol. 28:1989–1992.Google Scholar
  9. 9.
    Sershen, H., and Lajtha, A. 1979. Inhibition pattern by analogs indicates the presence of ten or more transport systems for amino acids in brain cells. J. Neurochem. 32:719–726.Google Scholar
  10. 10.
    Wade, L. A., and Brady, H. M. 1981. Cysteine and cystine transport at the blood-brain barrier. J. Neurochem. 37:730–734.Google Scholar
  11. 11.
    Horie, K., Morita, A., and Yokogoshi, H. 1995. Endothelin-1 and endothelin-3 modulate dopaminergic neurons through different mechanisms. Life Sci. 57:735–741.Google Scholar
  12. 12.
    Yokogoshi, H. 1985. Effect of dietary level of protein or methionine and threonine on the amino acids and catecholamines in brain of rats fed a high tyrosine diet. J. Nutr. Sci. Vitaminol. 31:519–531.Google Scholar
  13. 13.
    Paxinos, G., and Watson, C. 1986. The rat brain in stereotaxic coordinates, Academic Press, New York.Google Scholar
  14. 14.
    Duncan, D. B. 1957. Multiple-range tests for correlated and heteroscedastic means. Biometrics 13:164–176.Google Scholar
  15. 15.
    Pastuszko, A., Yee, D. K., and Wilson, D. F. 1986. Regulation of calcium uptake in synaptosomes from rat brain by D,L-2-amino-5-phosphonovaleric acid. FEBS Lett. 218:189–194.Google Scholar
  16. 16.
    Yee, D. K., Pastuszko, A., Nelson, D., and Wilso, D. F. 1989. Effects of DL-2-amino-5-phosphonovalerate on metabolism of catecholamines in synaptosomes from rat brain. J. Neurochem. 52:54–60.Google Scholar
  17. 17.
    Drewes, L. R., and Gilboe, D. D. 1973. Glycolysis and the permeation of glucose and lactate in the isolated, perfused dog brain during anoxia and postanoxic recovery. J. Biol. Chem. 248:2489–2496.Google Scholar
  18. 18.
    Fernstrom, J. D., and Wurtman, R. J. 1971. Brain serotonin content: physiological dependence on plasma tryptophan levels. Science 173:149–152.Google Scholar
  19. 19.
    Rubin, R. A., Ordonez, L. A., and Wurtman, R. J. 1974. Physiological dependence of brain methionine and S-adenosylmethionine concentrations on serum amino acid pattern. J. Neurochem. 23:227–231.Google Scholar
  20. 20.
    Cohen, E. L., and Wurtman, R. J. 1976. Brain acetylcholine: Control by dietary choline. Science 191:561–562.Google Scholar
  21. 21.
    Gibson, C. J., and Wurtman, R. J. 1978. Physiological control of brain norepinephrine synthesis by brain tyrosine concentration. Life Sci. 22:1399–1406.Google Scholar
  22. 22.
    Yokogoshi, H., and Wurtman, R. J. 1986. Meal composition and plasma amino acid ratios: Effect of various proteins or carbohydrates, and of various protein concentrations. Metabolism 35:837–842.Google Scholar
  23. 23.
    Yokogoshi, H., Iwata, T., Ishida, K., and Yoshida, A. 1987. Effect of amino acid supplementation to low protein diet on brain and plasma levels of tryptophan and brain 5-hydroxyindoles in rats. J. Nutr. 117:42–47.Google Scholar
  24. 24.
    Yokogoshi, H., Hayase, K., and Yoshida, A. 1992. The quality and quantity of dietary protein affect brain protein synthesis in rats. J. Nutr. 122:2210–2217.Google Scholar
  25. 25.
    Kitaoka, S., Hayashi, H., Yokogoshi, H., and Suzuki, Y. 1996. Transmural potential changes associated with the in vitro absorption of theanine in the guinea pig intestine. Biosci. Biotech. Biochem. 60:1768–1771.Google Scholar
  26. 26.
    Pardridge, W. M. 1977. Regulation of amino acid availability to the brain. Pages 141–204, in Wurtman, R. J., and Wurtman, J. J. (eds.), Nutrition and the brain, Raven Press, New York.Google Scholar
  27. 27.
    Shimizu, N., Duan, S., Hori, T., and Oomura, Y. 1990. Glutamate modulates dopamine release in the striatum as measured by brain microdialysis. Brain Res. Bull. 25:99–102.Google Scholar
  28. 28.
    Mayer, M. L., Westbrook, G. L., and Guthrie, P. B. 1984. Voltage-dependent block by Mg2+ of NMDA responses in spinal cord neurons. Nature 309:261–263.Google Scholar
  29. 29.
    Nowak, L., Bregestovski, P., Ascher, P., Herbert, A., and Prochiantnz, A. 1982. Magnesium gates glutamate-activated channels in mouse central neurons. Nature 307:462–465.Google Scholar

Copyright information

© Plenum Publishing Corporation 1998

Authors and Affiliations

  • Hidehiko Yokogoshi
    • 2
  • Miki Kobayashi
    • 1
  • Mikiko Mochizuki
    • 1
  • Takehiko Terashima
    • 1
  1. 1.School of Food and Nutritional SciencesThe University of ShizuokaYada, ShizuokaJapan
  2. 2.Laboratory of Nutritional Biochemistry, School of Food and Nutritional SciencesThe University of ShizuokaYada, ShizuokaJapan

Personalised recommendations